266 related articles for article (PubMed ID: 10973525)
1. Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
Stevenson GW; Cañadas F; Zhang X; Rice KC; Riley AL
Pharmacol Biochem Behav; 2000 Aug; 66(4):851-6. PubMed ID: 10973525
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
3. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
Picker MJ; Cook CD
Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
[TBL] [Abstract][Full Text] [Related]
4. Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose.
Grabus SD; Smurthwaite ST; Riley AL
Pharmacol Biochem Behav; 1999 Jul; 63(3):481-8. PubMed ID: 10418791
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid discrimination learning in the rat: assessment with the selective delta agonist SNC80.
Stevenson GW; Cañadas F; Gomez-Serrano M; Ullrich T; Zhang X; Rice KC; Riley AL
Pharmacol Biochem Behav; 2002; 71(1-2):283-92. PubMed ID: 11812534
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
[TBL] [Abstract][Full Text] [Related]
9. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
Negus SS; Morgan D; Cook CD; Picker MJ
Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
[TBL] [Abstract][Full Text] [Related]
11. Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.
Hutchinson AC; Simpson GR; Randall JF; Zhang X; Calderon SN; Rice KC; Riley AL
Pharmacol Biochem Behav; 2000 Aug; 66(4):779-87. PubMed ID: 10973516
[TBL] [Abstract][Full Text] [Related]
12. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Morgan D; Picker MJ
Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
[TBL] [Abstract][Full Text] [Related]
13. Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin.
Riley AL; Melton PM
Pharmacol Biochem Behav; 1997; 57(1-2):57-62. PubMed ID: 9164554
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning.
Davis CM; Stevenson GW; Cañadas F; Ullrich T; Rice KC; Riley AL
Psychopharmacology (Berl); 2009 Apr; 203(2):421-9. PubMed ID: 18594795
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
17. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
18. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors.
Rowlett JK; Spealman RD
Psychopharmacology (Berl); 1998 Nov; 140(2):217-24. PubMed ID: 9860113
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
